Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 2.11M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
11: R1 Document and Entity Information HTML 108K
12: R2 Consolidated Balance Sheet (Unaudited) HTML 135K
13: R3 Consolidated Balance Sheet (Unaudited) HTML 37K
(Parenthetical)
14: R4 Consolidated Statement of Income (Unaudited) HTML 109K
15: R5 Consolidated Statement of Comprehensive Income HTML 63K
(Unaudited)
16: R6 Consolidated Statement of Comprehensive Income HTML 31K
(Unaudited) (Parenthetical)
17: R7 Consolidated Statement of Cash Flows (Unaudited) HTML 92K
18: R8 Consolidated Statement of Redeemable HTML 104K
Noncontrolling Interest and Equity (Unaudited)
19: R9 Consolidated Statement of Shareholders' Equity HTML 19K
Consolidated Statement of Shareholders' Equity
(Unaudited) (Parenthetical)
20: R10 Nature of Operations and Summary of Significant HTML 36K
Accounting Policies
21: R11 Acquisitions HTML 24K
22: R12 Revenue and Contract-related Balances HTML 63K
23: R13 Business Segment and Geographical Information HTML 86K
24: R14 Income Taxes HTML 49K
25: R15 Earnings Per Share HTML 43K
26: R16 Debt and Other Financing Arrangements HTML 99K
27: R17 Commitments and Contingencies HTML 27K
28: R18 Comprehensive Income HTML 39K
29: R19 Fair Value Measurements and Fair Value of HTML 158K
Financial Instruments
30: R20 Supplemental Cash Flow Information HTML 38K
31: R21 Restructuring and Other Costs HTML 41K
32: R22 Nature of Operations and Summary of Significant HTML 30K
Accounting Policies (Policies)
33: R23 Acquisitions (Policies) HTML 22K
34: R24 Nature of Operations and Summary of Significant HTML 29K
Accounting Policies (Tables)
35: R25 Revenue and Contract-related Balances (Tables) HTML 60K
36: R26 Business Segment and Geographical Information HTML 134K
(Tables)
37: R27 Income Taxes (Tables) HTML 48K
38: R28 Earnings per Share (Tables) HTML 42K
39: R29 Debt and Other Financing Arrangements (Tables) HTML 88K
40: R30 Comprehensive Income (Tables) HTML 35K
41: R31 Fair Value Measurements and Fair Value of HTML 184K
Financial Instruments (Tables)
42: R32 Supplemental Cash Flow Information (Tables) HTML 39K
43: R33 Restructuring and Other Costs (Tables) HTML 41K
44: R34 Inventories (Details) HTML 28K
45: R35 Purchase Price Adjustments (Details) HTML 34K
46: R36 Revenue (Details) HTML 40K
47: R37 Revenue Performance Obligations (Details) HTML 28K
48: R38 Contract Assets and Liabilities (Details) HTML 32K
49: R39 Business Segment Information (Details) HTML 71K
50: R40 Geographical Information (Details) HTML 31K
51: R41 Income Taxes Rate Reconciliation (Details) HTML 52K
52: R42 Income Taxes - Unrecognized Tax Benefits (Details) HTML 28K
53: R43 Earnings Per Share (Details) HTML 49K
54: R44 Debt Outstanding Debt (Details) HTML 191K
55: R45 Debt Short-term Financing (Details) HTML 34K
56: R46 Comprehensive Income (Details) HTML 58K
57: R47 Fair Value Measurements, Assets and Liabilities HTML 58K
(Details)
58: R48 Fair Value Measurements and Fair Value of HTML 34K
Financial Instruments Fair Value, Liabilities
Measured on Recurring Basis, Unobservable Input
Reconciliation (Details)
59: R49 Fair Value Measurements, Derivative Assets & HTML 43K
Liabilities (Details)
60: R50 Fair Value Measurements, Derivative Instruments, HTML 50K
Gains & Losses (Details)
61: R51 Fair Value of Other Instruments (Details) HTML 33K
62: R52 Supplemental Cash Flow Information (Details) HTML 47K
63: R53 Restructuring and Other Costs (Details) HTML 38K
64: R54 Restructuring Reserves (Details) HTML 30K
67: XML IDEA XML File -- Filing Summary XML 120K
65: XML XBRL Instance -- tmo-20220702_htm XML 2.56M
66: EXCEL IDEA Workbook of Financial Reports XLSX 122K
7: EX-101.CAL XBRL Calculations -- tmo-20220702_cal XML 181K
8: EX-101.DEF XBRL Definitions -- tmo-20220702_def XML 485K
9: EX-101.LAB XBRL Labels -- tmo-20220702_lab XML 1.54M
10: EX-101.PRE XBRL Presentations -- tmo-20220702_pre XML 843K
6: EX-101.SCH XBRL Schema -- tmo-20220702 XSD 134K
68: JSON XBRL Instance as JSON Data -- MetaLinks 381± 586K
69: ZIP XBRL Zipped Folder -- 0000097745-22-000047-xbrl Zip 385K
CERTIFICATION REQUIRED BY EXCHANGE ACT RULES 13a-14(b) and 15d-14(b),
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Thermo Fisher Scientific Inc. (the “Company”) for the period ended July 2,
2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Marc N. Casper, Chairman, President and Chief Executive Officer of the Company, hereby certifies, pursuant to Securities Exchange Act of 1934 Rules 13a-14(b) and 15d-14(b), that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Marc N. Casper Chairman, President and Chief Executive Officer
A
signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Thermo Fisher Scientific Inc. and will be retained by Thermo Fisher Scientific Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Dates Referenced Herein and Documents Incorporated by Reference
